Status:
COMPLETED
Bioavailability of Prochlorperazine Suppositories, 25 mg
Lead Sponsor:
Padagis LLC
Conditions:
Healthy
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to compare prochlorperazine plasma concentrations produced after administration of the test formulation with those produced after administration of a marketed reference pr...
Eligibility Criteria
Inclusion
- Good health as determined by lack of clinically significant abnormalities in health assessment performed at screening
Exclusion
- Positive test results for HIV or Hepatitis B or C
- History of allergy or sensitivity to Prochlorperazine or related drugs
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00992472
Last Update
October 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PharmaKinetics Laboratories, Inc
Baltimore, Maryland, United States, 21201